Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement
- PMID: 1729421
- DOI: 10.1111/j.1471-4159.1992.tb09789.x
Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement
Abstract
Incubation of 10 mM 1-methyl-4-phenylpyridinium (MPP+) with sonicated beef heart mitochondria caused an irreversible time-dependent decrease in NADH-ubiquinone-1 (CoQ1) reductase activity (52% inhibition after 1 h). Inclusion of glutathione, ascorbate, or catalase in the incubation mixture protected the NADH-CoQ1 reductase activity. These results suggest that the interaction of MPP+ with complex I induces free radical generation, which in turn leads to the irreversible inhibition of complex I activity. The generation of free radicals by neurotoxin-induced inhibition of complex I has important implications for our interpretation of the increased oxidative stress observed in Parkinson's disease substantia nigra and for our understanding of the cause(s) of dopaminergic cell death in this disorder.
Similar articles
-
Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.J Neurochem. 1998 Nov;71(5):2049-62. doi: 10.1046/j.1471-4159.1998.71052049.x. J Neurochem. 1998. PMID: 9798930
-
The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.Biochim Biophys Acta. 1999 Jan 6;1453(1):49-62. doi: 10.1016/s0925-4439(98)00083-0. Biochim Biophys Acta. 1999. PMID: 9989245
-
Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion.J Neurochem. 1994 Aug;63(2):640-8. doi: 10.1046/j.1471-4159.1994.63020640.x. J Neurochem. 1994. PMID: 8035188
-
Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. doi: 10.1159/000046889. Biol Signals Recept. 2001. PMID: 11351130 Review.
-
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.Biochim Biophys Acta. 1995 May 24;1271(1):265-74. doi: 10.1016/0925-4439(95)00038-6. Biochim Biophys Acta. 1995. PMID: 7599219 Review.
Cited by
-
Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.Neurochem Res. 2005 Jun-Jul;30(6-7):713-9. doi: 10.1007/s11064-005-6865-9. Neurochem Res. 2005. PMID: 16187208
-
Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation.Biochem J. 2001 Oct 1;359(Pt 1):139-45. doi: 10.1042/0264-6021:3590139. Biochem J. 2001. PMID: 11563977 Free PMC article.
-
Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+).J Neural Transm (Vienna). 2011 Mar;118(3):421-31. doi: 10.1007/s00702-010-0489-1. Epub 2010 Oct 2. J Neural Transm (Vienna). 2011. PMID: 20890618
-
The oxidation of aminoethylcysteine ketimine dimer by oxygen reactive species.Amino Acids. 1994 Feb;7(1):83-8. doi: 10.1007/BF00808449. Amino Acids. 1994. PMID: 24185976
-
Catalytic antioxidants and neurodegeneration.Antioxid Redox Signal. 2009 Mar;11(3):555-70. doi: 10.1089/ars.2008.2256. Antioxid Redox Signal. 2009. PMID: 18754709 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources